Diabetic Foot Ulcer as a Cause of Significant Decline in the Renal Function Among South Indian Population With Type 2 Diabetes: Role of TGF-β1 and CCN Family Proteins.


Journal

The international journal of lower extremity wounds
ISSN: 1552-6941
Titre abrégé: Int J Low Extrem Wounds
Pays: United States
ID NLM: 101128359

Informations de publication

Date de publication:
Dec 2019
Historique:
pubmed: 16 7 2019
medline: 10 7 2020
entrez: 16 7 2019
Statut: ppublish

Résumé

In the present study, a total of 428 South Indian subjects were divided into four different groups, consisting of individuals with type 2 diabetes without any other complications (T2DM), T2DM subjects with stage 2 and 3 diabetic kidney disease (CKD), T2DM subjects with grade 2 or 3 diabetic foot ulcer (DFU) and T2DM subjects having both diabetic kidney disease and diabetic foot ulcer (CKDDFU). The study was conducted ambispectively by comparing the changes in renal function among two consecutive periods, i.e., the period prior to the development of grade 2 and 3 diabetic foot ulcer (retrospectively) and after the development of DFU (prospectively). A gradual and uniform reduction of eGFR was observed throughout the study period in the subjects affected with either CKD or DFU alone. Whereas in subjects with both CKD and DFU, there was a sharp decline in the eGFR during the six months prior to the baseline, i.e., the period in which the development of ulcer and its progression to grade 2 or 3 happened. Remarkable elevations in the levels of TGF-β1 and CCN2 (CTGF), as well as a significant reduction in the level of CCN3 (NOV), were observed in the serum of CKDDFU group subjects, compared to the other groups. Increased production of TGF-β1 in response to the inflammatory stimulus from multiple sites in CKDDFU subjects caused a subsequent down-regulation of CCN3, followed by the activation of a large quantity of CCN2.

Identifiants

pubmed: 31304816
doi: 10.1177/1534734619862704
doi:

Substances chimiques

Nephroblastoma Overexpressed Protein 0
Transforming Growth Factor beta1 0
Connective Tissue Growth Factor 139568-91-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

354-361

Auteurs

T P Smina (TP)

M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Centre, Chennai, India.

M Rabeka (M)

M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Centre, Chennai, India.

Vijay Viswanathan (V)

M.V. Hospital for Diabetes and Prof. M. Viswanathan Diabetes Research Centre, Chennai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH